Pharma Cos. Hit With $2M Judgment Over CBD Investor Fraud
A California federal judge has issued final judgments against a pharmaceutical company, its CEO and an affiliate on claims from the U.S. Securities and Exchange Commission that they defrauded investors of...To view the full article, register now.
Already a subscriber? Click here to view full article